THE vaccination hubs in district health centers commenced operations on Wednesday, July 6, according to the Davao City Covid-19 Task Force.

Spokesperson Dr. Michelle Schlosser said on Wednesday, July 6 that some district health centers have already opened such as in Puan and Bunawan while some are still finalizing their preparations.

“Hopefully all districts will be fully functional on Monday. Katong mga wala pa fixed hubs sa ilang (Areas without fixed hubs in their) district health offices, they are actually doing mobile vaccination para at least ma-cover nila ang mga days na wala pa nila na set up ilang vaccination hubs (to cover the missed days while they are still setting up the vaccination hubs),” Schlosser said during a radio interview.

The district health center-based vaccination hubs were initially supposed to open on July 4 but were delayed due to minor difficulties. Schlosser said they conducted a refresher on training and orientation of the medical vaccination personnel, as well as re-assignment of the staff.

“We have to make sure they are re-oriented on the policy. Apart from that, naa kasi mga bago pud na (we also have new) guidelines that they have to master as well,” Schlosser said.

All population groups will be catered to at the district health centers – A1 medical frontliners, A2 senior citizens, A3 persons with comorbidities, A4 essential workers, A5 indigents, and pediatric population of five to 17 years old.

However, the pediatric population of five to 11 years old will have a separate set of vaccination personnel to ensure they get the correct dosage of 0.2mL rather than the higher dosage of 0.3mL intended for 12 years old and above.

At the same time, immunocompromised individuals belonging to the 12 to 17 age group needing booster doses will have to proceed to the Southern Philippines Medical Center (SPMC) for a special rollout. A medical certificate, parent’s consent, and proof of age is also required.

According to the Davao City Information Office, the available vaccine brands are Sinovac, Pfizer, AstraZeneca, and Moderna for primary and booster vaccinations. ICM